Drug Database
SN

snake venom antibody-2 (ViperaTAb)

✓ Approved

MicroPharm · 多克隆抗体 · 多克隆抗体

什么是 snake venom antibody-2?

snake venom antibody-2 是一种多克隆抗体,由MicroPharm研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

商品名ViperaTAb
公司MicroPharm
药物类别多克隆抗体, 抗体
给药途径Injectable (Others), Intravenous (IV)
状态Approved

治疗适应症

snake venom antibody-2 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Injury, poisoning and procedural complicationsVenom poisoning✓ Approved

相关研究文献

PubMedRNA biology2026-11-19

The venom-gland small RNA transcriptome of the centipede Scolopendra subspinipes mutilans across the venom-release cycle.

Zhao Juan J, Zhao Fang F, Li Yonghong Y, Zhang Wuqiong W et al.

Venom production in centipedes is cyclical, but the small RNA content of the venom gland and its changes across the venom-release cycle have not been described. We sequenced nine small RNA libraries from venom glands of Scolopendra subspinipes mutilans, three at each of three stages: before release, and 0 h and 1 h after electrically induced venom release, and analysed the deposited reads with an open pipeline. miRNAs accounted for 47.6-65.2% of reads. Reads matched 52 conserved miRNA families with arthropod members, including the mandibulate-specific miR-965 and miR-282 and miR-125, which has not been found in the genome of the centipede Strigamia maritima. Reads of 24-30 nt outside known non-coding RNA classes made up 8.4-25.9% of each library; they were biased towards a 5' uridine, showed a strong ping-pong signature and, in a post hoc analysis, came preferentially from transcripts resembling transposable-element proteins, indicating piRNA-like small RNAs in this somatic tissue. No miRNA unit met the differential-abundance criteria of both DESeq2 and edgeR. For 53-65 of 272 miRNA units per comparison, the confidence interval excluded changes of two-fold or more, and simulations indicated that three libraries per stage detect a two-fold change with 14% power. novel-miR34, a predicted novel miRNA whose precursor lies within a transcript annotated as a CAP-superfamily venom allergen, was not significantly altered. A survey of 9,485 NCBI protein records annotated as venom allergens showed that this label is applied across many taxa. These data provide a replicated small RNA resource for a myriapod venom gland.

PMID 43053351
阅读全文 →
PubMedEcology and evolution2026-11-19

Exploring Snake Species Diversity, Habitat Suitability, and Threats in Two Protected Forests of Southeastern Bangladesh Using Field Observations and Ensemble Learning.

Rana Md Shohel MS, Biswas Sajib S, Washim Mahi M, Datta Ashis Kumar AK

This study aims to elucidate snake species richness, distribution patterns, habitat suitability and their conservation concern in Kaptai National Park (KNP) and Dudpukuria-Dhopachari Wildlife Sanctuary (DDWS), two biodiverse protected forests in Bangladesh's southeastern region. No comprehensive study of snakes in these two forests is available. By surveying 488.3 km through systematic transect sampling and opportunistic surveys, spending 1776 person-hours, we found 36 snake species (26 from KNP and 23 from DDWS) from 23 genera and eight families across the two study sites. Forest edge and hilly stream habitats exhibit the highest species richness and the most even species distributions at KNP. Whereas, DDWS revealed the highest species richness in hilly streams and waterlogged habitats, and greater evenness in forest edges and roadside vegetation. Habitat suitability models developed using Random Forest (for KNP) and Extreme Gradient Boosting (for DDWS) consistently identified climatic seasonality variables as the dominant predictors of snake distribution. Current suitability maps identified humid valley floors, riparian corridors, and evergreen hill forests as areas of high suitability in both protected areas. The habitat suitability model suggests that riparian corridors and moist evergreen forest patches should be well conserved to protect snakes from future changes. The findings significantly expand our understanding of snake species in two significant biodiversity-rich habitats, adding valuable information to national and global taxonomic databases and conservation planning efforts.

PMID 43053894
阅读全文 →
PubMedEmerging infectious diseases2026-11-19

Human Armillifer armillatus Infection Mimicking Strangulated Umbilical Hernia, France, 2026.

Devaux Jean-Maxime JM, Fleuriet Jules J, Leroy Camille C, Gangneux Jean-Pierre JP et al.

We report a case of Armillifer armillatus infection in Arras, France, in a woman originally from the Democratic Republic of the Congo. She manifested abdominal pain that mimicked a strangulated umbilical hernia. Clinicians should be aware of this parasitic infection, particularly in patients with a history of snake exposure.

PMID 43053251
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Receptor-Guided Targeted Protein Degradation Collapses Extracellular Vesicle-Driven Tumor-Stroma Crosstalk.

Kim Eun Hye EH, Park Byeongmin B, Kim Kyungsu K, Ryu Youngri Y et al.

Extracellular vesicles (EVs) are critical mediators of tumor-stromal communication within the tumor microenvironment (TME), where reciprocal signaling between cancer cells and cancer-associated fibroblasts (CAFs) fuels malignant progression and therapeutic resistance. Here, we report a degrader-antibody conjugate (DAC) platform, Ctx-ETAC, in which the clinically approved anti-EGFR antibody cetuximab (Ctx) delivers an engineered proteolysis-targeting chimera (PROTAC) payload, ETAC, selectively into EGFR-expressing tumor cells and activated CAFs via receptor-mediated endocytosis. ETAC integrates indomethacin as the COX-2 ligand, a VHL-recruiting peptide, and a cathepsin B (Cat-B)-cleavable azidoacetyl-RR linker; conjugation to Ctx was achieved by a two-step bioorthogonal strategy, yielding an average drug-to-antibody ratio of 4.21. The resulting Ctx-ETAC ensures biomarker-selective payload activation in both tumor cells and activated CAFs, markedly reducing EV secretion by 95.5% and thereby disrupting their crosstalk. This disruption of EV-mediated communication reprograms CAFs toward a quiescent phenotype and reshapes the non-small cell lung cancer microenvironment into an antitumor state. In a xenograft model, Ctx-ETAC achieves markedly superior tumor suppression compared with Ctx monotherapy, without systemic toxicity. These findings establish receptor-guided targeted protein degradation as a strategy to disrupt EV-driven tumor-stromal communication and provide a new framework for microenvironment-directed cancer therapy.

PMID 43053353
阅读全文 →
PubMedNPJ vaccines2026-11-19

Maternal influenza vaccination boosts durable breast milk antibody-mediated protection in infants.

Wessel Remziye E RE, Tong Xin X, Bhattacharya Allison A, Burrell Allison R AR et al.

Influenza contributes to significant disease burden worldwide, and young infants are at an increased risk of severe influenza infection. Maternal antibodies transferred across the placenta and through breast milk confer anti-influenza immunity to the newborn. Placental transfer provides a finite window of protection, but breast milk antibody transfer may provide prolonged immunity across the postnatal period. Yet, how breastmilk antibody profiles are shaped by maternal vaccination, change postnatally, and whether they contribute to protection against influenza remains incompletely defined. Comprehensive systems serological analysis of influenza-specific antibodies across 21 different antigens in a longitudinal birth cohort revealed maternal influenza vaccination was associated with enhanced antibody-dependent complement deposition (ADCD) and FcγR binding in breast milk at two weeks postpartum. This effect was further stratified by trimester of vaccination: first trimester vaccinees exhibited increased ADCD and IgM levels, whereas second or third trimester vaccination was associated with increased FcγR and FcαR binding. Analysis of longitudinal samples revealed that anti-influenza antibody responses in milk shift postpartum toward increased FcγR binding and decreased ADCD activity and IgM levels. Finally, baseline ADCD activity in breast milk and serum IgG1 levels were identified as signatures of resistance to influenza infection during the first six months of life. A multivariate model combining correlates of protection across milk and serum compartments offered greater predictive power compared to either compartment alone, suggesting both routes of antibody transfer bolster anti-influenza immunity in infants. These data collectively suggest that maternal influenza vaccination confers infant protection via breast milk to augment placental antibody transfer, and the functional capacity of these protective antibodies could be enhanced with prolonged breastfeeding.

PMID 43052358
阅读全文 →
PubMedJournal of hematology & oncology2026-11-19

Antibody-drug conjugates in HR-positive, HER2-negative metastatic breast cancer: evolving clinical roles and translational directions.

Lin Shengbo S, Zeng Cheng C, Liu Xuan X, Bao Xinyue X et al.

Rapid advances in antibody-drug conjugates (ADCs) and an expanding clinical evidence base are reshaping treatment options for hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (mBC). Randomized trials have demonstrated progression-free survival benefits over chemotherapy for individual ADCs in defined populations, including settings before and after metastatic chemotherapy. As additional ADCs become available and indications expand, attention is increasingly focused on whether individual agents can improve outcomes over endocrine-based regimens in selected endocrine-eligible patients and on which therapies beyond conventional chemotherapy may retain activity after ADC progression. Addressing these questions requires integration of clinical evidence with a mechanistic understanding of ADC activity and resistance. In this review, we summarize selected mechanisms of ADC action and critically examine the evolving clinical roles of individual agents across settings defined by prior therapy. We also discuss treatment strategies after ADC exposure and resistance mechanisms relevant to target and payload selection. Finally, we review exploratory studies of candidate biomarkers associated with clinical outcomes, ADC-based combinations, and next-generation designs, highlighting their biological rationale, emerging evidence, and priorities for further evaluation.

PMID 43053184
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多snake venom antibody-2